| [1] Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Advanced Drug Delivery Reviews, 2012,64(7):640-665.
[2] Alyautdin R, Khalin I, Nafeeza M I,et al. Nanoscale drug delivery systems and the blood-brain barrier. International Journal of Nanomedicine, 2014,9:795-811.
[3] Tajes M, Ramos-Fernandez E, Weng-Jiang X,et al. The blood-brain barrier:structure, function and therapeutic approaches to cross it. Molecular Membrane Biology, 2014,31(5):152-167.
[4] Zhang F, Xu C L, Liu C M. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma. Drug Design, Development and Therapy, 2015,2015(9):2089-2100.
[5] Wang X, Yu X, Vaughan W,et al. Novel drug-delivery approaches to the blood-brain barrier. Neuroscience Bulletin, 2015,31(2):257-264.
[6] Upadhyay R K. Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Research International, 2014,2014:869269.
[7] Farkhani S M, Valizadeh A, Karami H,et al. Cell penetrating peptides:Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules. Peptides, 2014,57(7):78-94.
[8] Bicker J, Alves G, Fortuna A,et al. Blood-brain Barrier Models and Their Relevance for a Successful Development of CNS Drug Delivery Systems:A Review. European Journal of Pharmaceutics and Biopharmaceutics:Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik eV, 2014,87(3):409-432.
[9] Blanchette M, Tremblay L, Lepage M,et al. Impact of Drug Size on Brain Tumor and Brain Parenchyma Delivery After a Blood-brain Barrier Disruption. Journal of Cerebral Blood Flow and Metabolism:Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 2014,34(5):820-826.
[10] Aronica E, Gorter J A, Jansen G H,et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy:focal cortical dysplasia and glioneuronal tumors. Neuroscience, 2003,118(2):417-429.
[11] Parrish K E, Sarkaria J N, Elmquist W F. Improving drug delivery to primary and metastatic brain tumors:strategies to overcome the blood-brain barrier. Clinical Pharmacology and Therapeutics, 2015,97(4):336-346.
[12] Azad T D, Pan J, Connolly I D,et al. Therapeutic strategies to improve drug delivery across the blood-brain barrier. Neurosurgical Focus, 2015,38(3):E9.
[13] Cooper I, Last D, Guez D,et al. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors. Journal of cerebral blood flow and metabolism:official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015,35(6):967-976.
[14] Crawford L, Rosch J, Putnam D. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system. Journal of Controlled Release:Official Journal of the Controlled Release Society, 2015,doi:10.1016/j.jconrel.2015,12.041.
[15] Pardridge W M. Targeted delivery of protein and gene medicines through the blood-brain barrier. Clinical Pharmacology and Therapeutics, 2015,97(4):347-361.
[16] Pardridge W M. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody. Expert Opinion on Drug Delivery, 2015,12(2):207-222.
[17] Miyake M M, Bleier B S. The blood-brain barrier and nasal drug delivery to the central nervous system. American Journal of Rhinology & Allergy, 2015,29(2):124-127. |
